Simplex Trading
IMVT icon

Simplex Trading’s Immunovant IMVT Stock Holding History

Simplex Trading’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Buy
51,080
+804
+2% +$24.5K ﹤0.01% 2060
2026
Q1 		$1.25M Buy
50,276
+1,865
+4% +$48.3K ﹤0.01% 2270
2025
Q4 		$1.23M Buy
48,411
+33,479
+224% +$747K ﹤0.01% 2425
2025
Q3 		$240K Buy
14,932
+10,126
+211% +$164K ﹤0.01% 4718
2025
Q2 		$76K Buy
+4,806
New +$72.7K ﹤0.01% 5495
2025
Q1 		– Sell
-86,847
Closed -$1.82M – 9012
2024
Q4 		$2.15M Buy
86,847
+38,656
+80% +$1.1M ﹤0.01% 2128
2024
Q3 		$1.37M Sell
48,191
-8,770
-15% -$259K ﹤0.01% 2608
2024
Q2 		$1.5M Buy
56,961
+31,972
+128% +$909K ﹤0.01% 2482
2024
Q1 		$807K Sell
24,989
-52,493
-68% -$1.92M ﹤0.01% 3348
2023
Q4 		$3.26M Sell
77,482
-47,730
-38% -$1.76M ﹤0.01% 1922
2023
Q3 		$4.81M Buy
125,212
+104,706
+511% +$2.37M ﹤0.01% 1383
2023
Q2 		$388K Buy
20,506
+4,652
+29% +$86.8K ﹤0.01% 3566
2023
Q1 		$245K Buy
15,854
+7,362
+87% +$128K ﹤0.01% 4096
2022
Q4 		$150K Sell
8,492
-1,085
-11% -$13.7K ﹤0.01% 4587
2022
Q3 		$53K Buy
9,577
+9,522
+17,313% +$46.5K ﹤0.01% 6370
2022
Q2 		$0 Buy
+55
New +$238 ﹤0.01% 10454
2022
Q1 		– Sell
-4,019
Closed -$25K – 10861
2021
Q4 		$34K Sell
4,019
-6,781
-63% -$56K ﹤0.01% 7733
2021
Q3 		$122K Buy
10,800
+6,296
+140% +$56.8K ﹤0.01% 6334
2021
Q2 		$47K Buy
+4,504
New +$62.9K ﹤0.01% 7705

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Simplex Trading's IMVT Position: Q2 2026 in Review

Simplex Trading increased its Immunovant (IMVT) stake by 1.6% in Q2 2026, buying an estimated $24.5K and bringing the position to 51,080 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2060.

Simplex Trading first reported a position in IMVT in Q2 2021 and has held it in 19 quarters since. The position peaked at $4.81M in Q3 2023. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Simplex Trading held 51,080 shares of Immunovant worth $1.97M as of Q2 2026.
  • Simplex Trading bought 804 Immunovant shares in Q2 2026, an estimated $24.5K.
  • Immunovant made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #2060 holding.
  • Simplex Trading first reported a position in Immunovant in Q2 2021 and has held it in 19 quarters since.
  • Simplex Trading's Immunovant position peaked at $4.81M in Q3 2023.
  • 227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.